Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2786623 | 0.90 | THRB (1.00) | THRBTHRA | |
| SCHEMBL2788880 | 0.90 | THRB (1.00) | THRBTHRA | |
| SCHEMBL2786910 | 0.88 | THRB (0.82) | THRBTHRA | |
| SCHEMBL2786567 | 0.88 | THRB (0.82) | THRBTHRA | |
| SCHEMBL2786784 | 0.87 | THRB (0.77) | THRBTHRA | |
| SCHEMBL2786644 | 0.87 | THRB (0.85) | THRBTHRA | |
| SCHEMBL2786463 | 0.87 | THRB (0.89) | THRBTHRA | |
| SCHEMBL2788934 | 0.86 | THRB (0.65) | THRBTHRA | |
| SCHEMBL2787290 | 0.85 | THRB (0.74) | THRBTHRA | |
| SCHEMBL2790080 | 0.85 | THRB (0.80) | THRBTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7557143-B2 | Thyroid receptor ligands | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-07-07 | — | — | US | claimed |
| US-8263659-B2 | Thyroid receptor ligands | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-09-11 | — | — | US | disclosed |
| US-20100298276-A1 | THYROID RECEPTOR LIGANDS | BRISTOL-MYERS SQUIBB COMPANY | 2010-11-25 | — | — | US | disclosed |
| US-7557143-B2 | Thyroid receptor ligands | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-07-07 | — | — | US | disclosed |
| US-20050004184-A1 | Thyroid receptor ligands | BRISTOL-MYERS SQUIBB COMPANY | 2005-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298276-A1 | THYROID RECEPTOR LIGANDS | TSHR, THRA, THRB | THRB 3/4885THRA 2/4885 |
| US-20050004184-A1 | Thyroid receptor ligands | TSHR, THRA, THRB | THRB 3/4885THRA 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.